drugset / Trial / NCT00887679

Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS

NCT00887679

Phase 3 Completed 30 enrolled Duke University Forest Laboratories · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate whether escitalopram is safe, well tolerated, and effective in the treatment of HIV-infected patients with generalized anxiety disorder.

Timeline

Start
2009-05
Primary completion
2009-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg Oral